8-K:NRx Pharmicals(纳斯达克股票代码:NRXP)公布2024年第一季度财务业绩并提供业务最新情况
8-K:重大事件
8-K:重大事件
NRX PHARMACEUTICALS INC C/WTS 24/05/2026 (TO PUR COM) | 8-K:重大事件
NRX PHARMACEUTICALS INC C/WTS 24/05/2026 (TO PUR COM) | 8-K:NRx Pharmicals(纳斯达克股票代码:NRXP)公布2023年第四季度和全年财务业绩并提供业务最新情况
NRX PHARMACEUTICALS INC C/WTS 24/05/2026 (TO PUR COM) | 8-K:重大事件
NRX PHARMACEUTICALS INC C/WTS 24/05/2026 (TO PUR COM) | 8-K:重大事件
NRX PHARMACEUTICALS INC C/WTS 24/05/2026 (TO PUR COM) | DEFA14A:其他
NRX PHARMACEUTICALS INC C/WTS 24/05/2026 (TO PUR COM) | DEFA14A:其他
NRX PHARMACEUTICALS INC C/WTS 24/05/2026 (TO PUR COM) | DEFA14A:其他
NRX PHARMACEUTICALS INC C/WTS 24/05/2026 (TO PUR COM) | DEF 14A:股东委托书决议
NRX PHARMACEUTICALS INC C/WTS 24/05/2026 (TO PUR COM) | 8-K:重大事件
NRX PHARMACEUTICALS INC C/WTS 24/05/2026 (TO PUR COM) | 8-K:重大事件
NRX PHARMACEUTICALS INC C/WTS 24/05/2026 (TO PUR COM) | 8-K:重大事件
NRX PHARMACEUTICALS INC C/WTS 24/05/2026 (TO PUR COM) | 8-K:重大事件
NRX PHARMACEUTICALS INC C/WTS 24/05/2026 (TO PUR COM) | 8-K:重大事件
NRX PHARMACEUTICALS INC C/WTS 24/05/2026 (TO PUR COM) | 8-K:重大事件
NRX PHARMACEUTICALS INC C/WTS 24/05/2026 (TO PUR COM) | PRE 14A:并购重组委托声明
NRX PHARMACEUTICALS INC C/WTS 24/05/2026 (TO PUR COM) | 8-K:重大事件
NRX PHARMACEUTICALS INC C/WTS 24/05/2026 (TO PUR COM) | 8-K:重大事件
暂无数据